Industry · Healthcare

AI for healthcare

006

Stories synthesized for this industry

All industries:Finance Healthcare Legal Marketing Education Government Manufacturing Media Retail Nonprofit Developer Tools Research

Everyday AI

AI won't diagnose you. It will prepare you to be diagnosed.

230 million people per week ask ChatGPT health questions. Most of them are asking what's wrong with them — when the useful question is whether AI can help them explain what's happening to someone qualified to answer. Here's the preparation-not-diagnosis workflow that actually works.

Jul 11

SkepticRegulation

ChatGPT is auditing your state's Medicaid money. Nobody published what it gets wrong.

The Department of Health and Human Services launched AERO in May — an AI tool built in part with ChatGPT scanning five-plus years of audit history across all 50 states. Enforcement can include withholding Medicaid funding. HHS has published no error rate, no appeals timeline, and no enforcement start date.

Jul 8

BuilderPaper

An AI proposed a drug discovery fix. The wet lab ran 10,080 experiments to check. It held.

OpenAI's GPT-5.4 and Molecule.one's Maria AI ran a three-month chemistry collaboration and published the result June 17: AI proposed TEMPO as the fix for a difficult drug synthesis reaction; 10,080 physical wet-lab experiments later, the hypothesis survived. Average yield improved from 16.6% to 25.2%. This is the first publicly documented case of a frontier model driving a real wet-lab chemistry discovery.

Jun 19

AcademicPaper

Eighteen children. Years without answers. Then the AI read the literature.

OpenAI's o3 Deep Research model helped researchers at Boston Children's Hospital find diagnoses for 18 previously unsolvable pediatric cases — a 4.8% additional yield on top of prior specialist work. Published in NEJM AI on June 18, 2026. Seven of those 18 answers were already hiding in public medical databases; no one had connected them to the right child.

Jun 19

BuilderSafety

OpenAI's drug discovery model just became a government biodefense tool.

GPT-Rosalind launched in April 2026 for pharma research, topping the BixBench bioinformatics benchmark at 0.751 Pass@1. On May 29, OpenAI extended it to US government biodefense partners including Lawrence Livermore National Laboratory and CEPI. The benchmark holds. The governance structure is more restricted than anything OpenAI has shipped before.

May 30

BuilderProduct

Google's 8th-gen TPU launched alongside the Enterprise Agent Platform. The chip is the boring half.

Google shipped the 8th-generation TPU and the Gemini Enterprise Agent Platform in the same month. The chip is the obvious announcement. The agent platform is where the strategic move is. Here's what Google is actually building and what it competes with.

Apr 30

🌿